Evaluation of neural damage in Duchenne muscular dystrophy patients

Acta Myologica

Volumn 33, Issue 1, 2014, Pages 13-18

  Salam, Ekram Abdel ^a   Abdel Meguid, Iman Ehsan ^a   Shatla, Rania ^b   Korraa, Soheir ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY   (Egypt)

Author keywords

Cognitive function; Duchenne muscular dystrophy; Neural damage

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CD34 ANTIGEN; CD45 ANTIGEN; NERVE GROWTH FACTOR; NESTIN;

ARTICLE; BRAIN DAMAGE; CELL COUNT; CHILD; COGNITION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EVALUATION STUDY; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NERVE INJURY; NERVE REGENERATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHOOL CHILD;

COGNITIVE FUNCTION; DUCHENNE MUSCULAR DYSTROPHY; NEURAL DAMAGE;

ANTIGENS, CD34; ANTIGENS, CD45; CASE-CONTROL STUDIES; CHILD; COGNITION DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; NERVE GROWTH FACTOR; NESTIN;

EID: 84900547793     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Emery AE. The muscular dystrophies. Lancet 2002;359:687-95.
2. Moser H. Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention. Hum Genet 1984,66:17-40.
3. Cullen MJ, Mastaglia FL. Morphological changes in dystrophic muscle. Br Med Bull 1980;36:145-52.
4. Billard C, Gillet P, Signoret JL, et al. Cognitive functions in duchenne muscular dystrophy: a reappraisal and comparison with spinal muscular atrophy. Neuromuscular Disorders 1992:2:371-8.
5. Billard C, Gillet P, Barthez M-A, et al. Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy. Developmental Medicine and Child Neurology 1998;40:12-20.
6. Hinton VJ, De Vivo BC, Nereo NE, et al. Poor verbal working memory across intellectual level in boys with Duchenne dystrophy. Neurolog 2000;54:2127-32.
7. Hinton VJ, De Vivo DC, Nereo NE, et al. Selective deficits in verbal working memory associated with a known genetic etiology: the neuropsychological profile of Duchenne muscular dystrophy. Journal of the International Neuropsychological Society 2001:7:45-54.
8. Roccella M, Pace R, De Gregorio MT. Psychopathological assessment in children affected by Duchenne de Boulogne muscular dystrophy. Minerva Pediatrica 2003;55:267-76.
9. Walter J, Kaether C, Steiner H, et al. The cell biology of Alzheimer's disease: uncovering the secrets of secretases. Curr Opin Neurobiol 2001:11:585-90.
10. Hardy J, Selkoe D. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002:297:353-6.
11. Seubert P, Vigo-Pelfrey C, Esch F, et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 1992:359:325-7.
12. Walsh D, Klyubin I, Fadeeva J, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002:416:535-9.
13. Selkoe D. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 2008:192:106-13.
14. Barde YA. Neurotrophins: a family of proteins supporting the survival of neurons. Prog Clin Biol Res 1994:390:1855-9.
15. Tuszynski M, Blesch A. Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease. Prog Brain Res 2004:146:441-9.
16. Sun W, Sun C, Lin H, et al. The effect of collagen binding NGFbeta on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model. Biomaterials 2009:30:4649-56.
17. Brazelton T, Rossi F, Keshet G, et al. From Marrow to Brain: Expression of Neuronal Phenotypes in Adult Mice. Science 2000:290:1775-9.
18. Guo X, Liu L, Zhang M, et al. Correlation of CD34+ cells with tissue angiogenesis after traumatic brain injury in a rat model. J Neurotrauma 2009:26:1337-44.
19. Hennemann B, Ickenstein G, Sauerbruch S, et al. Mobilization of CD34+ hematopoietic cells, colony-forming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. Cytotherapy 2008;10:303-11.
20. Zwart I, Hill A, Girdlestone J, et al. Analysis of neural potential of human umbilical cord blood-derived multipotent mesenchymal stem cells in response to a range of neurogenic stimuli. J Neuroscience Res 2008:86:1902-15.
21. Anderson JL, Head SI, Rae C, et al. Brain function in Duchenne muscular dystrophy. Brain 2002:125:4-13.
22. Decano JL, Moran AM, Giordano N, et al. Analysis of CD45-[CD34+/KDR+] endothelial progenitor cells as juvenile protective factors in a rat model of ischemic-hemorrhagic stroke. PLoS One 2013:8:e55222.
23. Li Y, Zhang C, Xiong F, et al. Comparative study of mesenchymal stem cells from C57BL/10 and mdx mice. BMC Cell Biol 2008:19;9:24-32.
24. Xia W, Yang T, Shankar G, et al. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Arch Neurol 2009:66:190-9.
25. Duda D, Cohen K, Scadden D, et al. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007:2:805-810.
26. Antonucci MT, Bonofiglio R, Papalia T, et al. Nerve growth factor and its monocyte receptors are affected in kidney disease. Nephron Clin Pract 2009:111:c21-c28.
27. Wechsler D. Wechsler Intelligence Scale for Children. 3rd ed. San Antonio, TX: Psychological Corp 1991.
28. Pane M, Lombardo ME, Alfieri P, et al. Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. J Pediatr 2012:161:705-9.
29. Marchi N, Angelov L, Masaryk T, et al. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 2007:48:732-42.
30. Tsao C, Mendell J. Coexisting muscular dystrophies and epilepsy in children. J Child Neurol 2006:21:148-50.
31. De Sarro G, Ibbadu G, Marra R, et al. Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice. Neurosci Res 2004:50:37-44.
32. Nico B, Corsi P, Ria R, et al. Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse. Neuroscience 2006:140:835-48.
33. Abdel-Meguid I, Abdel-Salam E, Latif D, et al. Markers of neural degeneration and regeneration in Down syndrome patients. Egyptian Journal of Medical Human Genetics 2013:14:49-53.
34. Matsubara E, Ghiso J, Frangione B, et al. Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome. Ann Neurol 1999:45:537-41.
35. Mehta D, Dalton J, Mehta P, et al. Increased plasma amyloid beta protein 1-42 levels in Down syndrome. Neurosci Lett 1998:241:13-6.
36. Schupf N, Patel B, Silverman W, et al. Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome. Neurosci Lett 2001:301:199-203.
37. Tokuda T, Fukushima T, Ikeda S, et al. Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome. Ann Neurol 1997:41:271-3.
38. Zigman WB, Schupf N, Sersen E, et al. Prevalence of dementia in adults with and without Down syndrome. Am J Ment Retard 1996:100:403-12.
39. Nico B, Paola Nicchia G, et al. Altered blood-brain barrier development in dystrophic MDX mice. Neuroscience 2004;125:921-35.
40. Tinsley JM, Blake DJ, Pearce M, et al. Dystrophin and related proteins. Curr Opin Genet Dev 1993;3:484-90.
41. Moizard MP, Billard C, Toutain A, et al. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? Am J Med Genet 1998;80:32-41.
42. Moizard MP, Toutain A, Fournier D. Severe cognitive impairment in DMD: Obvious clinical indication for Dp71 isoform point mutation screening. Eur J Hum Genet 2000;8:552-6.
43. Daoud F, Angeard N, Demerre B. Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression. Hum Mol Genet 2009;18:3779-94.
44. Felisari G, Martinelli Boneschi F, Bardoni A. Loss of Dp140 dystrophin and intellectual impairment in Duchenne dystrophy. Neurology 2000;55:559-64.
45. Wingeier K, Giger E, Strozzi S. Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy. J Clin Neurosci 2011;18:90-5.
46. Bardoni A, Felisari G, Sironi M. Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies. Neuromuscul Disord 2000;10:194-9.
47. Taylor PJ, Betts GA, Maroulis S. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS One 2010;5:e8803.
48. Perronnet C, Cyrille C. Dystrophins, Utrophins, and Associated Scaffolding Complexes: Role in Mammalian Brain and Implications for Therapeutic Strategies. J Biomed. Biotechnol 2010:2010:849426-45.
49. Baydur A, Gilgoff I, Prentice W, et al. Decline in respiratory function and experience with long-term assisted ventilation in advanced Duchenne's muscular dystrophy. Chest 1990:97:884-9.
50. Toti P, Villanova M, Vatti R, et al. Nerve growth factor expression in human dystrophic muscles. Muscle Nerve 2003:27:370-3.
51. Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of a cellular nerve grafts. Brain Res 1999:846:219-28.
52. Calza L, Giardino L, Giuliani A, et al. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc Natl Acad Sci USA 2001:98:4160-5.
53. Nico B, Mangieri D, De Luca A, et al. Nerve growth factor and its receptors TrkA and p75 are upregulated in the brain of mdx dystrophic mouse. Neuroscience 2009:161:1057-66.
54. Hirota M, Furukawa Y, Shinoda I, et al. Changes in nerve growth factor content of the submaxillary gland in the genetically dystrophic (mdx) mouse. J Neurol Sci 1994:121:176-82.
55. Guo X, Liu L, Zhang M, et al. Correlation of CD34+ cells with tissue angiogenesis after traumatic brain injury in a rat model. J Neurotrauma 2009:26:1337-44.
56. Sjöberg G, Edström L, Lendahl U, et al. Myofibers from Duchenne/Becker muscular dystrophy and myositis express the intermediate filament nestin. J Neuropathol Exp Neurol 1994:53:416-23.
57. Satz JS, Ostendorf AP, Hou S, et al. Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain. J Neurosci 2010:30:14560-72.
58. Wei LC, Shi M, Chen LW, et al. Nestin-containing cells express glial fibrillary acidic protein in the proliferative regions of central nervous system of postnatal developing and adult mice. Brain Res Dev Brain Res 2002:139:9-17.
59. Yu TS, Zhang G, Liebl DJ, et al. Traumatic brain injury-induced hippocampal neurogenesis requires activation of early nestin-expressing progenitors. J Neurosci 2008:28:12901-12.
60. Rivier F, Alkan O, Flint AF, et al. Role of bone marrow cell trafficking in replenishing skeletal muscle SP and MP cell populations. J Cell Sci 2004:117:1979-88.
61. Ojima K, Uezumi A, Miyoshi H, et al. Mac-1(low) early myeloid cells in the bone marrow-derived SP fraction migrate into injured skeletal muscle and participate in muscle regeneration. Biochem Biophys Res Commun 2004:321:1050-61.
62. Barbosa da Fonseca LM, Gutfilen B, Rosado de Castro PH, et al. Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Experimental Neurology 2010:221:122-8.
63. Zhu Y, Hou H, Rezai-Zadeh K, et al. CD45 deficiency drives amyloid-â peptide oligomers and neuronal loss in Alzheimer's disease mice. J Neurosci 2011:31:1355-65.